Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000582538 | SCV000687371 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000702900 | SCV000831775 | benign | Ataxia-telangiectasia syndrome | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000582538 | SCV001175751 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000582538 | SCV002536480 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-03-15 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV004592815 | SCV005083803 | benign | Familial cancer of breast | 2024-05-08 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |